The purpose of this study was to determine if nociceptive and/or neuropathic pain in advanced cancer patients could be identified by word selections made on the McGill Melzack Pain Questionnaire. Theoretical definitions for nociceptive and neuropathic pain provided a framework for categorizing the word descriptors in the McGill Melzack Pain Questionnaire's sensory and miscellaneous dimensions. A description study design was used to group word frequencies by primary site and pain type. The participants were 76 advanced cancer patients who received home-based hospice services. A wide range of word choices for lung cancer patients supported both nociceptive and neuropathic pain. Individuals with colon and liver cancer selected words that described 2 types of nociceptive (visceral, somatic) pain, while those with prostate cancer noted somatic pain. A set frequency was not reached by individuals with breast, pancreatic, gastric, and other advanced cancers. This study provided evidence that advanced cancer patients select words that describe nociceptive and neuropathic pain types.
Payne R.Cancer pain: anatomy, physiology, and pharmacology. Cancer . 1989;63:2266-2274.
2.
Twycross R., Harcourt J., Bergl S.A survey of pain in patients with advanced cancer. J Pain Symptom Manage. 1996;12:273-282.
3.
Zeppetella G. , O'Doherty CA, Collins S.Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symptom Manage. 2000;20:87-92.
4.
Banning A., Sjogren P., Henriksen H.Pain causes in 200 patient referred to a multidisciplinary cancer pain clinic . Pain. 1991;45:45-48.
5.
Payne R.Anatomy, physiology, and neuropharmacology of cancer pain. Med Clin N Am. 1987;71:153-167.
Van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M., Patijn J.Prevalence of pain in patients with cancer: a systematic review. Ann Oncol . 2007;18:1437-1449.
8.
Melzack R.The McGill pain questionnaire: major properties and scoring methods . Pain. 1975;1:277-299.
9.
Dubuisson D. , Melzack R.Classification of clinical pain descriptions by multiple group discriminant analysis. Exp Neurology. 1976;51:480-487.
10.
Graham C., Bond SS, Gerkovich MM, Cook MRUse of the McGill Pain Questionnaire in the assessment of cancer pain: replicability and consistency. Pain. 1980;8:377-387.
11.
Tearnan BH, Cleeland CSUnaided use of pain descriptors by patients with cancer pain. J Pain Symptom Manage. 1990;5:228-232.
12.
Zimmerman L. , Duncan K., Pozehl B., Schmitz R.Pain descriptors used by patients with cancer . Oncol Nurs Forum. 1987;14:67-71.
13.
Caraceni A. , Portenoy RKAn international survey of cancer pain characteristics and syndromes. Pain. 1999;82: 263-274.
14.
Grond S., Zech D., Diefenbach C., Radbruch L., Lehmann KAAssessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996;64:107-114.
15.
Manfredi PL , Gonzales GR, Sady R., Chandler S., Payne R.Neuropathic pain in patients with cancer. J Palliat Care. 2003;19:115-118.
16.
Burrows M., Dibble SL, Miaskowski C.Differences in outcomes among patients experiencing different types of cancer-related pain. Oncol Nurs Forum. 1998;25: 735-741.
17.
Harden N., Cohen M.Unmet needs in the management of neuropathic pain. J Pain Symptom Manage. 2003;25(suppl 5):S12-S17.
18.
Martin LA, Hagen NANeuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies . J Pain Symptom Manage. 1997 ;14:99-117.
19.
Bennett MI, Attal N., Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain. 2007;127: 199-203.
20.
Dobratz MCPatterns of advanced cancer pain in home hospice patients. Cancer Nurs. 2001;24:294-299.
21.
Chang VT, Janjan N., Jain S., Chau C.Update in cancer pain syndromes. J Palliat Med. 2006;9:1414-1434.
22.
Portenoy RKThe physical examination in cancer pain assessment . Sem Oncol Nurs. 1997;13:25-29.
23.
Boureau F., Doubrere JF, Luu M.Study of verbal description in neuropathic pain. Pain. 1990;42:145-152.
24.
Stute P., Soukup J., Menzel M., Sabatowski R., Grond S.Analysis and treatment of different types of neuropathic cancer pain . J Pain Symptom Manage. 2003;26:1123-1131.
25.
Wilkie DJ, Huang H.-Y, Reilly N., Cain KCNociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage. 2001;22:899-910.
26.
Urch C.The pathophysiology of cancer-induced bone pain: current understanding . Palliat Med. 2004;18: 267-274.
27.
Fainsinger RL, Nekolaichuk CL, Lawlor PG, Neumann CM, Hanson J., Vigano A.A multicenter study of the revised Edmonton staging system for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage. 2005;29:224-237.
28.
Chong SM, Bajwa ZHDiagnosis and treatment of neuropathic pain. J Pain Symptom Manage. 2003;25(suppl 5): S4-S11.
29.
Stromgren AS , Groenvold M., Petersen MA, et al. Pain characteristics and treatment outcome for advanced cancer patients during the first week of specialized care. J Pain Symptom Manage. 2004 ;27:104-113.
30.
Cherny NI, Thaler HT, Freidlander-Klar H., et al. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology. 1994;44: 857-861.
31.
Lorenz KA, Lynn J., Dy S., et al. Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med. 2008;148:147-159.
32.
Tsai J.-S., Wu C-H., Chiu T.-Y., Hu W-Y., Chen C.-Y.Symptom patterns of advanced cancer patients in a palliative care unit. Palliat Med. 2006;20:617-622.
